AIC
ALT icon

Ameritas Investment Company’s Altimmune ALT Stock Holding History

Ameritas Investment Company’s Portfolio ALT Stock Details ALT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-3
Closed – – 381
2020
Q1 		$0 Buy
+3
New +$7 ﹤0.01% 1752
2019
Q4 		– Sell
-3
Closed – – 864
2019
Q3 		$0 Buy
+3
New +$7 ﹤0.01% 1632
2019
Q2 		– Sell
-3
Closed – – 251
2019
Q1 		$0 Buy
+3
New +$9 ﹤0.01% 964

Other funds holding ALT

VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
ACP
Acuta Capital Partners Redwood City, California $142M AUM 783.79% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Ameritas Investment Company's ALT Position: Q2 2020 in Review

Ameritas Investment Company sold out of Altimmune (ALT) in Q2 2020, closing a stake of 3 shares.

Ameritas Investment Company first reported a position in ALT in Q1 2019 and held it in 3 quarters. The position peaked at $0 in Q1 2020. 57 funds tracked by Wall St. Rank hold ALT as of Q2 2020.

  • Ameritas Investment Company reported no remaining Altimmune position as of Q2 2020 after selling out during the quarter.
  • Ameritas Investment Company sold 3 Altimmune shares in Q2 2020.
  • Ameritas Investment Company first reported a position in Altimmune in Q1 2019 and held it in 3 quarters.
  • Ameritas Investment Company's Altimmune position peaked at $0 in Q1 2020.
  • 57 funds tracked by Wall St. Rank held Altimmune as of Q2 2020.

Based on Ameritas Investment Company's 13F filing for Q2 2020, filed 14 Aug 2020.